Graphique 1 - Toubkal

77- Bigot S, Leblond P, Foucher C et al.- Apport du dosage de la procalcitonine pour le diagnostic de pyélonéphriteaiguë de l’enfant.- Archives de pédiatrie, 2005 (12) : 1075–1080.78- Stockland E, Hellström M, Jacobsson B, et al.- Early 99mTc dimercaptosuccinic acid (DMSA) scintigraphy in symptomaticfirst-time urinary tract infection.- Acta Paediatr 1996;85:430–6.79- Biggi A, Dardanelli L, Pomero G, et al.- Acute renal cortical scintigraphy in children with a first urinary tractinfection.- Pediatr Nephrol 2001;16:733–8.80- Benador D, Benador N, Slosman DO, et al.- Cortical scintigraphy in the evaluation of renal parenchymal changes inchildren with pyelonephritis.- J Pediatr 1994;124:17–20.81- Benador N, Siegrist CA, Gendrel D, et al.- Procalcitonin is a marker of severity of renal lesions in pyelonephritis.- Pediatrics 1998;102:1422–5.82- Gervaix A, Galetto-Lacour A, Gueron T, et al.- Usefulness of procalcitonin and C-reactive protein rapid tests for themanagement of children with urinary tract infection.- Pediatr Infect Dis J 2001; 20 : 507–11.83- Smolkin V, Koren A, Raz R, et al.- Procalcitonin as a marker of acute pyelonephritis in infants and children.- Pediatr Nephrol 2002;17:409 – 12.169